# FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)

> **NCT07497893** · NA · NOT_YET_RECRUITING · sponsor: **Ewha Womans University Mokdong Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Upper Gastrointestinal Bleeding (UGIB)
- Gastrointestinal Hemorrhage (Clinically Important, Upper)
- Drug-Related Side Effects and Adverse Reactions

## Interventions

- **DRUG:** Fexuprazan
- **DRUG:** NOAC therapy

## Key facts

- **NCT ID:** NCT07497893
- **Lead sponsor:** Ewha Womans University Mokdong Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2029-11-30
- **Final completion:** 2032-11-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07497893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07497893, "FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07497893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*